Healthtech Startups

Companion connects animal health and wellness professionals with expertise and resources in animal pain management. The company serves practitioners across animal health and wellness sectors.

5 investors

Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration. A University of Manchester spinout, it runs clinical and natural history studies in ophthalmology across the US and UK.

5 investors

RealTime provides software systems for managing clinical trial operations across research sites, networks, academic medical centers, CROs, and sponsors. The platform includes site operations management, case management, electronic regulatory documents, source data, payments, and patient engagement tools.

5 investors

Concha Labs makes Concha Sol, an FDA-cleared over-the-counter self-fitting hearing aid that uses patented technology to personalize a user's sound profile, with a focus on hearing speech in noisy environments. The devices are aimed at individuals with mild-to-moderate hearing loss and are set up at home.

5 investors

Harvard University is an educational institution founded in 1636 that conducts research, offers undergraduate and graduate degree programs, and provides online learning to millions of learners globally. The university serves students, researchers, faculty, and a global community of alumni and online learners across multiple academic disciplines.

5 investors

Contego Medical develops the Neuroguard IEP System, a 3-in-1 carotid stenting device combining a carotid stent, dilation balloon, and integrated embolic protection with a 40-micron filter to reduce stroke and cognitive impairment from microembolization. The company also produces peripheral vascular devices; Medtronic is now the sole U.S. distributor of the carotid product.

5 investors

Convexia provides AI-powered drug discovery and evaluation software that scans global sources for overlooked drug assets and runs deep in silico simulations across 50+ models to assess binding, toxicity, pharmacokinetics, and immunogenicity. The platform combines AI agents with expert human review to accelerate drug asset evaluation for biotech companies, pharma firms, and venture investors.

5 investors

Counsel develops AI solutions to expand clinical capacity in healthcare. The company brings together physicians, AI researchers, and technologists to address fundamental challenges in how patients receive care.

5 investors

COUR develops antigen-specific immunotherapies that reprogram the immune system to treat the underlying causes of autoimmune and immune-mediated diseases while preserving normal immune function. The company is advancing a pipeline of disease-modifying therapies aimed at patients with a range of autoimmune conditions.

5 investors

Craniometrix provides AI-powered care navigation and support services to help dementia patients remain at home while reducing hospitalizations for their families and caregivers.

5 investors

CUDIS builds a smart wearable ring with AI-powered coaching for daily recovery, anti-aging, and wellness. The platform combines biometric data from the device with personalized guidance and community features for athletes and everyday users across 103 countries.

5 investors

CuraFi provides a drug risk and cost management solution aimed at expanding patient access to specialty medication. It is built by a team of clinicians and technologists to address barriers to patient care for healthcare organizations.

5 investors

Curai Health offers virtual primary care through a chat-based service, connecting patients with a care team of medical experts for diagnosis, treatment, prescription renewals, and management of conditions such as flu, hypertension, and diabetes. It serves individuals with or without insurance for a monthly fee paid by the patient or their employer.

5 investors

Curana Health provides on-site primary care and value-based care for senior housing residents, operating Accountable Care Organizations (ACOs) and Medicare Advantage Special Needs Plans. It partners with senior living and skilled nursing operators across the United States to deliver care to seniors in assisted living and similar communities.

5 investors

CURE operates a booking platform that connects pharmacies with delivery service partners to generate online orders. The platform provides integration with point-of-sale systems, product data management, and marketing campaigns for German-speaking pharmacies.

5 investors

Cured builds cloud-based enterprise software for healthcare organizations to modernize operations and improve patient and employee experiences. The company provides technology solutions that enable healthcare providers and payers to execute strategic initiatives through agile, consumer-grade platforms.

5 investors

Current Surgical develops a smart needle technology platform for surgical treatment of cancerous tumors. The company serves surgeons and oncologists in the medical device and cancer care space.

5 investors

CurvaFix develops the CurvaFix Low Profile intramedullary nailing system, curved implants for surgical stabilization of pelvic fractures. The devices are used by orthopedic trauma surgeons and orthopedic oncologists and are FDA-cleared for use in the United States.

5 investors

Curve Health operates a telemedicine platform combined with data analytics and health information exchange that connects bedside providers with remote clinicians. It focuses on long-term care, serving nursing home and skilled nursing facility residents, their caregivers, and clinicians.

5 investors

CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.

5 investors

Vivante Health is a digital health company focused on gastrointestinal (GI) care, developing data-driven, value-based health programs and technology for managing digestive conditions.

5 investors

CytomX is a clinical-stage biopharmaceutical company developing conditionally activated biologic cancer therapies, including antibody-based treatments designed to target tumors while limiting effects on healthy tissue. It advances a pipeline of Probody therapeutics through preclinical research and clinical trials in oncology.

5 investors

Darmiyan develops medical AI and brain imaging software for early detection and monitoring of neurodegenerative diseases, particularly Alzheimer's. The platform targets healthcare providers, patients, and pharmaceutical companies seeking to advance brain health and disease prevention.

5 investors

Data-Driven Bioscience develops Duoseq, a cancer genomics platform that performs simultaneous DNA and RNA analysis from a single sample, delivering comprehensive molecular profiling results in two days for use in clinical diagnostics and research.

5 investors